Darius Kharabi Kala Pharmaceuticals, Inc. (KALA) insider trading activity

Darius Kharabi is CHIEF BUSINESS OFFICER of Kala Pharmaceuticals, Inc.. Currently has a direct ownership of 41,760 shares of KALA, which is worth approximately $29,649. The most recent transaction as insider was on Oct 22, 2025, when has been sold 20,806 shares (Common Stock) at a price of $0.83 per share, resulting in proceeds of $17,268. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.8K

33.25% 3M change

30.08% 12M change

Total Value Held $29,649

Darius Kharabi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 22 2025	SELL Open market or private sale	$17,268 $0.83 p/Share	20,806 Reduced 33.25%	41,760 Common Stock
Jun 24 2025	SELL Open market or private sale	$18,089 $4.01 p/Share	4,511 Reduced 6.73%	62,566 Common Stock
Jun 03 2025	SELL Open market or private sale	$2,730 $3.74 p/Share	730 Reduced 1.08%	67,077 Common Stock
Jan 06 2025	SELL Open market or private sale	$15,420 $7.63 p/Share	2,021 Reduced 2.89%	67,807 Common Stock
Jan 06 2025	BUY Grant, award, or other acquisition	-	10,100 Added 12.64%	69,828 Common Stock
Jun 26 2024	SELL Open market or private sale	$24,500 $4.75 p/Share	5,158 Reduced 7.95%	59,728 Common Stock
May 31 2024	SELL Open market or private sale	$1,406 $6.09 p/Share	231 Reduced 0.35%	64,886 Common Stock

Jan 04 2024	SELL Open market or private sale	$9,321 $6.73 p/Share	1,385 Reduced 2.08%	65,117 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	4,600 Added 6.47%	66,502 Common Stock
Jun 22 2023	BUY Grant, award, or other acquisition	-	36,847 Added 37.31%	61,902 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	2,648 Added 9.56%	25,055 Common Stock
Mar 10 2023	BUY Grant, award, or other acquisition	-	6,977 Added 23.74%	22,407 Common Stock
Jan 04 2023	BUY Grant, award, or other acquisition	-	9,525 Added 38.15%	15,439 Common Stock
Feb 15 2022	SELL Other acquisition or disposition	-	9 Reduced 0.06%	15,430 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	295,657 Added 50.0%	295,657 Common Stock

Darius Kharabi

CHIEF BUSINESS OFFICER

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALA shares.

Notify only if

Value

Insider Trading

Get notified when an Kala Pharmaceuticals, Inc. insider buys or sells KALA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kala Pharmaceuticals, Inc.

Track Activities on KALA

Account